Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score,JHEP Reports

当前位置： X-MOL 学术 › JHEP Reports › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score
JHEP Reports ( IF 9.5 ) Pub Date : 2024-06-03 , DOI: 10.1016/j.jhepr.2024.101127
Pimsiri Sripongpun _{1,

2} , Apichat Kaewdech ₁ , Prowpanga Udompap ₃ , W Ray Kim ₂

Affiliation

The new nomenclature of steatotic liver disease (SLD) was recently launched with sub-classifications of metabolic dysfunction-associated SLD (MASLD), MASLD with increased alcohol intake (MetALD), and alcohol-related liver disease (ALD). Herein, we aimed to evaluate the characteristics and long-term outcomes associated with these subgroups and the utility of non-invasive biomarkers.

中文翻译：

MASLD 、 MetALD 和 ALD 个体的特征和长期死亡率，以及 SAFE 评分的效用

脂肪性肝病（SLD）的新命名法最近推出，对代谢功能障碍相关 SLD （MASLD）、酒精摄入量增加的 MASLD （MetALD）和酒精相关性肝病（ALD）进行了子分类。在此，我们旨在评估与这些亚组相关的特征和长期结果以及非侵入性生物标志物的效用。

更新日期：2024-06-03

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文